The 7th International Conference On Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease

第七届小儿和先天性心脏病临床和工程前沿国际会议

• 批准号: 9763076
• 负责人: Mark A Fogel
• 金额: $ 1.75万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-05-09 至 2020-05-08
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9763076
• 关键词: Adult; Award; Biomedical Engineering; Birth; Cause of Death; Childhood; Clinical; Clinical Engineering; Clinical Medicine; Collaborations; Communities; Congenital Abnormality; Country; Defect; Diagnostic; Discipline; Disease; Engineering; Faculty; Fostering; Funding; Goals; Individual; International; Mechanics; Medical; Medical Care Costs; Medicine; Minority Participation; Oral; Participant; Patients; Physicians; Population; Quality of life; Research; Research Personnel; STEM field; Scientist; Series; Societies; Source; Technology; Travel; Underrepresented Groups; Underrepresented Minority; Universities; Ursidae Family; Woman; age related; congenital heart disorder; doctoral student; frontier; graduate student; hemodynamics; improved; infant death; meetings; member; next generation; posters; programs; research and development; role model; symposium; tool; treatment planning

Project Summary and Abstract Congenital heart disease (CHD) is the leading cause of death for infants born with birth defects and represents 1% of births in the US. Successful treatment of CHD offers opportunities to improve quality of life for these individuals with consequent benefit to society. Over 1 million adults in the US are living with CHD. While there has been much progress with applying engineering fundamentals to understand and CHD over the past decades, there remains more to accomplish. To help focus engineers and physicians, the 6th International Conference on Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease, the meeting this project proposes, will bring together leading professionals in both engineering and medical disciplines to foster collaboration between the 2 communities in the study of treatment of CHD. Concurrently, the conference will serve as a platform to encourage the next generation of engineers and scientists to continue pursuing treatments for CHD. By bringing together these 2 groups, there is an opportunity to advance current treatment, identify under- researched defects and bring engineering to bear as an aid to physicians in understanding hemodynamic and mechanical aspects of the disease, improving and developing diagnostic tools and technology, and improving treatment planning. Therefore, a conference focused on CHD can achieve improved treatment and understanding of this age-related disease that afflicts a significant segment of the US population and the consequent reduction of medical costs associated with CHD accompanied by an improved patient quality of life. The conference will offer support to members of underrepresented groups involved in biomedical engineering research in pediatric and congenital heart disease, thus upholding the national goal of engaging underrepresented groups into the STEM disciplines. This conference also provides successful role models for women, 2 who are on the international organizing and steering committee, who have established vibrant research programs and labs in this field. This is the 6th iteration of this conference and we seek to maintain the continuity of the International Conference on Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease series that effectively brings together leading researchers in engineering and medicine who are engaged in cutting edge research in CHD. This is an excellent forum to exchange ideas and build of collaborations between leading researchers from around the world. Moreover, the conference promotes new researchers becoming engaged in the field through the Young Investigator podium speaker program and its young investigator poster competition. Our conference objective is to request support for the 6th in this series of international conferences on the engineering research in pediatric and congenital heart disease which has historically attracted both USA and international participants, affording an international forum for exchange of ideas and research.

项目概要和摘要 先天性心脏病 (CHD) 是导致出生缺陷婴儿死亡的主要原因 占美国出生人口的 1%。冠心病的成功治疗为这些人提供了改善生活质量的机会 从而为社会带来利益的个人。美国有超过 100 万成年人患有先心病。在那里 过去几十年来，在应用工程基础知识来理解 CHD 方面取得了很大进展， 还有更多工作要做。为了帮助工程师和医生集中精力，第六届国际会议 儿科和先天性心脏病的临床和工程前沿，该项目提出的会议， 将汇集工程和医学学科的领先专业人士以促进合作 两个社区之间的冠心病治疗研究。同时，本次会议将作为 平台鼓励下一代工程师和科学家继续寻求冠心病的治疗方法。 通过将这两组结合在一起，就有机会推进当前的治疗，识别不足 研究缺陷并将工程学应用于帮助医生了解血流动力学和 疾病的机械方面，改进和开发诊断工具和技术，并改进 治疗计划。因此，专注于 CHD 的会议可以改善治疗和 了解这种困扰美国很大一部分人口的与年龄相关的疾病以及 与 CHD 相关的医疗费用随之减少，同时患者的生活质量得到改善。 该会议将为生物医学领域代表性不足的群体成员提供支持 儿科和先天性心脏病的工程研究，从而维护国家参与的目标 代表性不足的群体进入 STEM 学科。本次会议还为以下人士提供了成功的榜样 女性，其中 2 名是国际组织和指导委员会成员，她们建立了充满活力的 该领域的研究计划和实验室。 这是本次会议的第六次迭代，我们力求保持国际会议的连续性 儿科和先天性心脏病临床和工程前沿会议系列 有效地汇集了从事前沿研究的工程和医学领域的领先研究人员 冠心病研究。这是一个绝佳的论坛，可以在领先的企业之间交流想法并建立合作 来自世界各地的研究人员。此外，会议还促进新的研究人员从事 通过青年研究者讲台演讲者计划及其青年研究者海报竞赛来扩大该领域的影响力。 我们的会议目标是请求对本系列国际会议中的第六次会议的支持 儿科和先天性心脏病的工程研究历史上吸引了美国 和国际参与者，提供一个交流思想和研究的国际论坛。